- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05552989
Towards Better Preparedness for Future Catastrophes - Local Lessons-learned From COVID-19
Towards Better Preparedness for Future Catastrophes - a Qualitative Mixed Methods Study of Lessons Learned From Civil-military Disaster Response in Heidelberg, Germany, During the COVID-19 Pandemic
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Design, execution, analysis and publication of this study is conducted in compliance with the international quality criteria "STrengthening the Reporting of OBservational studies in Epidemiology (STROBE)" and "Standards for Reporting Qualitative Research (SRQR)".
This is a monocentric, qualitative, mixed-methods, non-interventional, non-randomized research project.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Heidelberg, Germany
- University Hospital Heidelberg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age over 18 years
- Direct or indirect involvement in civil-military collaboration during the COVID-19 crisis
- Ability to provide consent
- Providing written informed consent to participate in the study
Exclusion Criteria:
1) Failure to provide written informed consent to participate in the study
Study Plan
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Key stakeholders of the local disaster relief community
|
this is a non-interventional study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Civil-military disaster relief support to Heidelberg, Germany, during the COVID-19 crisis
Time Frame: Years 2020 to 2022
|
Autoethnographic qualitative, empiric-observational analysis
|
Years 2020 to 2022
|
From civilian capability gaps towards societal resilience
Time Frame: One session of 2 hours (cross-sectional assessment at interview appointment)
|
Structured interview with key stakeholders of the local disaster relief community
|
One session of 2 hours (cross-sectional assessment at interview appointment)
|
From lessons-learned towards better future disaster preparedness
Time Frame: One session of 2 hours (cross-sectional assessment at interview appointment)
|
Structured interview with key stakeholders of the local disaster relief community
|
One session of 2 hours (cross-sectional assessment at interview appointment)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Markus Ries, MD, PhD, MHSc, FCP, Heidelberg University
Publications and helpful links
General Publications
- Schulze C, Welker A, Kuhn A, Schwertz R, Otto B, Moraldo L, Dentz U, Arends A, Welk E, Wendorff JJ, Koller H, Kuss D, Ries M. Public Health Leadership in a VUCA World Environment: Lessons Learned during the Regional Emergency Rollout of SARS-CoV-2 Vaccinations in Heidelberg, Germany, during the COVID-19 Pandemic. Vaccines (Basel). 2021 Aug 11;9(8):887. doi: 10.3390/vaccines9080887.
- Ries M. Global key concepts of civil-military cooperation for disaster management in the COVID-19 pandemic-A qualitative phenomenological scoping review. Front Public Health. 2022 Sep 15;10:975667. doi: 10.3389/fpubh.2022.975667. eCollection 2022.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-534/2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emergencies
-
Betsi Cadwaladr University Health BoardRecruitingMedical EmergenciesUnited Kingdom
-
Universidad de AntioquiaCompleted
-
Second Affiliated Hospital, School of Medicine,...UnknownMedical EmergenciesChina
-
Central Hospital, Nancy, FranceCompleted
-
Technische Universität DresdenCompletedPerformance in Simulated Emergencies | Stress During Simulator Scenario | Behaviour of Physicians in Simulated EmergenciesGermany
-
Charite University, Berlin, GermanyZentralinstitut für die Kassenärztliche Versorgung in DeutschlandUnknownNon-urgent EmergenciesGermany
-
Peking University People's HospitalBeijing Emergency Medical Center; Beijing Red Cross Emergency CenterCompletedEmergencies [Disease/Finding]China
-
M.D. Anderson Cancer CenterRecruitingOncologic Complications and EmergenciesUnited States
-
Copenhagen Academy for Medical Education and SimulationCompletedCardiopulmonary Resuscitation | Education | Medical Emergencies
-
Mbarara University of Science and TechnologyUniversity of CalgaryCompletedMaternal, Pediatric Care EmergenciesUganda
Clinical Trials on this is a non-interventional study
-
Sanguine BiosciencesRecruiting
-
Hull University Teaching Hospitals NHS TrustUniversity of YorkRecruiting
-
Amicus TherapeuticsEngage Health Inc.CompletedFabry DiseaseUnited States
-
University of MalayaMichael J. Fox Foundation for Parkinson's Research; University of Dundee; Nextcea... and other collaboratorsUnknown
-
International Institute of Behavioral MedicinesRecruiting
-
University of PlymouthNot yet recruitingDiabetic Peripheral Neuropathy | Painful Diabetic Neuropathy
-
KK Women's and Children's HospitalUniversity of PlymouthActive, not recruitingCritical Illness | Pediatric ALL | Post Intensive Care Unit SyndromeSingapore
-
Notable LabsCompletedLymphoma | Myelodysplastic Syndromes | Multiple Myeloma | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloproliferative NeoplasmSpain, United States, Greece
-
Medlior Health Outcomes Research LtdCompletedChronic Kidney Diseases | Type 2 Diabetes
-
University Hospital of CologneClinic for Internal Medicine I, University Hospital Cologne, Germany; Institute... and other collaboratorsUnknownCOVID-19 | SARS-CoV-2Germany